Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1001
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $73.3M | 0.01% |
1,074,410
+52,276
| +5% | +$3.41M |
|
1002
MasTec
MTZ
$21.1B
| $72.7M | 0.01% |
685,458
-260,225
| -28% | -$28.3M |
|
1003
Acadia Healthcare
ACHC
$2.76B
| $72.5M | 0.01% |
1,156,054
+31,820
| +3% | +$2M |
|
1004
Valvoline
VVV
$4.9B
| $72.4M | 0.01% |
2,231,585
+40,789
| +2% | +$1.27M |
|
1005
Exelixis
EXEL
$13.3B
| $72.4M | 0.01% |
3,973,240
+51,112
| +1% | +$1.19M |
|
1006
Regal Rexnord
RRX
$13.7B
| $72.4M | 0.01% |
542,172
+4,283
| +0.8% | +$605K |
|
1007
Advanced Drainage Systems
WMS
$10.6B
| $72.1M | 0.01% |
618,580
-241,961
| -28% | -$26.9M |
|
1008
LivaNova
LIVN
$4.4B
| $72.1M | 0.01% |
857,214
+32,318
| +4% | +$2.66M |
|
1009
Signet Jewelers
SIG
$3.61B
| $72.1M | 0.01% |
892,003
+20,520
| +2% | +$1.33M |
|
1010
Antero Resources
AR
$11.1B
| $71.7M | 0.01% |
4,771,853
+483,610
| +11% | +$5.68M |
|
1011
QuidelOrtho
QDEL
$1.14B
| $71.6M | 0.01% |
558,533
-10,675
| -2% | -$1.26M |
|
1012
Avis
CAR
$4.86B
| $71.4M | 0.01% |
917,185
+24,096
| +3% | +$2M |
|
1013
Community Bank
CBU
$3.41B
| $71.4M | 0.01% |
943,827
+87,348
| +10% | +$6.88M |
|
1014
National Vision
EYE
$1.77B
| $71.4M | 0.01% |
1,396,309
+62,205
| +5% | +$3.05M |
|
1015
Timken Company
TKR
$9.56B
| $71.2M | 0.01% |
883,713
-64,561
| -7% | -$5.46M |
|
1016
Range Resources
RRC
$9.38B
| $71.2M | 0.01% |
4,249,264
+391,638
| +10% | +$4.91M |
|
1017
Moog Inc Class A
MOG.A
$12.4B
| $70.9M | 0.01% |
843,201
+62,583
| +8% | +$5.41M |
|
1018
Highwoods Properties
HIW
$3.65B
| $70.8M | 0.01% |
1,568,068
+26,271
| +2% | +$1.18M |
|
1019
Under Armour
UAA
$2.84B
| $70.7M | 0.01% |
3,349,821
+6,075
| +0.2% | +$135K |
|
|
APLS
1020
DELISTED
Apellis Pharmaceuticals
APLS
| $70.7M | 0.01% |
1,118,135
+71,222
| +7% | +$3.68M |
|
1021
Hawaiian Electric Industries
HE
$2.23B
| $70.5M | 0.01% |
1,666,516
+121,901
| +8% | +$5.28M |
|
1022
Black Hills Corp
BKH
$5.42B
| $70.4M | 0.01% |
1,073,182
+47,508
| +5% | +$3.23M |
|
1023
Houlihan Lokey
HLI
$8.77B
| $70.4M | 0.01% |
861,085
+27,017
| +3% | +$1.96M |
|
1024
Ionis Pharmaceuticals
IONS
$8.6B
| $70.3M | 0.01% |
1,762,540
+33,394
| +2% | +$1.31M |
|
1025
Apple Hospitality REIT
APLE
$3.9B
| $70.3M | 0.01% |
4,603,690
+644,307
| +16% | +$10M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.